Bree B Aldridge

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 27

Top Venues

Expert opinion on drug discovery

mBio

bioRxiv : the preprint server for biology

Microbiology spectrum

Tufts University School of Medicine

Massachusetts Institute of Technology (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Tufts University School of Medicine Jul 01 2012

United States

Assistant Professor :: Molecular Biology and Microbiology

Education History

Massachusetts Institute of Technology Sep 01 2002 - Jun 01 2008

United States

PHD :: Biological Engineering

University of Arizona

United States

BSC :: Molecular and Cellular Biology

University of Arizona

United States

BSC :: Computer Engineering

Publications

Kathleen P Davis, Laura A McDermott, David R Snydman, Bree B Aldridge
In vitro identification of underutilized β-lactam combinations against methicillin-resistant Staphylococcus aureus bacteremia isolates. Microbiology spectrum (2024)
Megan W Tse, Meilin Zhu, Benjamin Peters, Efrat Hamami, Julie Chen, Kathleen P Davis, Samuel Nitz, Juliane Weller, Thulasi Warrier, Diana K Hunt, Yoelkys Morales, Tomohiko Kawate, Jeffrey L Gaulin, Jon H Come, Juan Hernandez-Bird, Wenwen Huo, Isabelle Neisewander, Laura L Kiessling, Deborah T Hung, Bree B Aldridge, Ralph R Isberg, Paul C Blainey
Massively parallel combination screen reveals small molecule sensitization of antibiotic-resistant Gram-negative ESKAPE pathogens. bioRxiv : the preprint server for biology (2024)
Kathleen P Davis, Laura A McDermott, David R Snydman, Bree B Aldridge
In vitro identification of underutilized β-lactam combinations against methicillin-resistant Staphylococcus aureus bacteremia isolates. Microbiology spectrum (2024)
Kathleen P Davis, Yoelkys Morales, Rachel J Ende, Ryan Peters, Anne L McCabe, Joan Mecsas, Bree B Aldridge
Critical role of growth medium for detecting drug interactions in Gram-negative bacteria that model in vivo responses. mBio 15 (3) (2024)
Kathleen P Davis, Yoelkys Morales, Rachel J Ende, Ryan Peters, Anne L McCabe, Joan Mecsas, Bree B Aldridge
Critical role of growth medium for detecting drug interactions in Gram-negative bacteria that model in vivo responses. mBio 15 (3) (2024)
Megan W Tse, Meilin Zhu, Benjamin Peters, Efrat Hamami, Julie Chen, Kathleen P Davis, Samuel Nitz, Juliane Weller, Thulasi Warrier, Diana K Hunt, Yoelkys Morales, Tomohiko Kawate, Jeffrey L Gaulin, Jon H Come, Juan Hernandez-Bird, Wenwen Huo, Isabelle Neisewander, Laura L Kiessling, Deborah T Hung, Bree B Aldridge, Ralph R Isberg, Paul C Blainey
Massively parallel combination screen reveals small molecule sensitization of antibiotic-resistant Gram-negative ESKAPE pathogens. bioRxiv : the preprint server for biology (2024)
Kathleen P Davis, Yoelkys Morales, Rachel J Ende, Ryan Peters, Anne L McCabe, Joan Mecsas, Bree B Aldridge
Critical role of growth medium for detecting drug interactions in Gram-negative bacteria that model in vivo responses. mBio 15 (3) (2024)
Kathleen P Davis, Yoelkys Morales, Rachel J Ende, Ryan Peters, Anne L McCabe, Joan Mecsas, Bree B Aldridge
Critical role of growth medium for detecting drug interactions in Gram-negative bacteria that model in vivo responses. mBio (2024)
Megan W Tse, Meilin Zhu, Benjamin Peters, Efrat Hamami, Julie Chen, Kathleen P Davis, Samuel Nitz, Juliane Weller, Thulasi Warrier, Diana K Hunt, Yoelkys Morales, Tomohiko Kawate, Jeffrey L Gaulin, Jon H Come, Juan Hernandez-Bird, Wenwen Huo, Isabelle Neisewander, Laura L Kiessling, Deborah T Hung, Joan Mecsas, Bree B Aldridge, Ralph R Isberg, Paul C Blainey
Massively parallel combination screen reveals small molecule sensitization of antibiotic-resistant Gram-negative ESKAPE pathogens. bioRxiv : the preprint server for biology (2024)
Kathleen P Davis, Laura A McDermott, David R Snydman, Bree B Aldridge
In vitro identification of underutilized β-lactam combinations against methicillin-resistant Staphylococcus aureus bacteremia isolates. Microbiology spectrum 12 (8) (2024)
Eun Seon Chung, Prathitha Kar, Maliwan Kamkaew, Ariel Amir, Bree B Aldridge
Mycobacterium tuberculosis grows linearly at the single-cell level with larger variability than model organisms. bioRxiv : the preprint server for biology (2023)
Nhi Van, Yonatan N Degefu, Pathricia A Leus, Jonah Larkins-Ford, Jacob Klickstein, Florian P Maurer, David Stone, Husain Poonawala, Cheleste M Thorpe, Trever C Smith, Bree B Aldridge
Novel Synergies and Isolate Specificities in the Drug Interaction Landscape of Mycobacterium abscessus. Antimicrobial agents and chemotherapy (2023)
Jonah Larkins-Ford, Bree B Aldridge
Advances in the design of combination therapies for the treatment of tuberculosis. Expert opinion on drug discovery (2022)
Eun Seon Chung, William C Johnson, Bree B Aldridge
Types and functions of heterogeneity in mycobacteria. Nature reviews. Microbiology 20 (9) (2022)
Jonah Larkins-Ford, Bree B Aldridge
Advances in the design of combination therapies for the treatment of tuberculosis. Expert opinion on drug discovery 18 (1) (2022)
Laura Paulowski, Katherine S H Beckham, Matt D Johansen, Laura Berneking, Nhi Van, Yonatan Degefu, Sonja Staack, Flor Vasquez Sotomayor, Lucia Asar, Holger Rohde, Bree B Aldridge, Martin Aepfelbacher, Annabel Parret, Matthias Wilmanns, Laurent Kremer, Keith Combrink, Florian P Maurer
C25-modified rifamycin derivatives with improved activity against Mycobacterium abscessus . PNAS nexus 1 (4) (2022)
Jonah Larkins-Ford, Bree B Aldridge
Advances in the design of combination therapies for the treatment of tuberculosis. Expert opinion on drug discovery 18 (1) (2022)
Qingyun Liu, Junhao Zhu, Charles L Dulberger, Sydney Stanley, Sean A Wilson, Eun Seon Chung, Xin Wang, Peter Culviner, Yue J Liu, Nathan D Hicks, Gregory H Babunovic, Samantha R Giffen, Bree B Aldridge, Ethan C Garner, Eric J Rubin, Michael C Chao, Sarah M Fortune
Tuberculosis treatment failure associated with evolution of antibiotic resilience. Science (New York, N.Y.) 378 (6624) (2022)
Jonah Larkins-Ford, Bree B Aldridge
Advances in the design of combination therapies for the treatment of tuberculosis. Expert opinion on drug discovery (2022)
Jonah Larkins-Ford, Bree B Aldridge
Advances in the design of combination therapies for the treatment of tuberculosis. Expert opinion on drug discovery (2022)
Jonah Larkins-Ford, Bree B Aldridge
Advances in the design of combination therapies for the treatment of tuberculosis. Expert opinion on drug discovery 18 (1) (2022)
Laura Paulowski, Katherine S H Beckham, Matt D Johansen, Laura Berneking, Nhi Van, Yonatan Degefu, Sonja Staack, Flor Vasquez Sotomayor, Lucia Asar, Holger Rohde, Bree B Aldridge, Martin Aepfelbacher, Annabel Parret, Matthias Wilmanns, Laurent Kremer, Keith Combrink, Florian P Maurer
C25-modified rifamycin derivatives with improved activity against Mycobacterium abscessus . PNAS nexus 1 (4) (2022)
Jonah Larkins-Ford, Bree B Aldridge
Advances in the design of combination therapies for the treatment of tuberculosis. Expert opinion on drug discovery 18 (1) (2022)
Bree B Aldridge, David Barros-Aguirre, Clifton Earl Barry, Robert H Bates, Steven J Berthel, Helena I M Boshoff, Kelly Chibale, Xin-Jie Chu, Christopher B Cooper, Veronique Anne Dartois, Ken Duncan, Nader Fotouhi, Fabian Gusovsky, Philip A Hipskind, Dale J Kempf, Joël Lelièvre, Anne J Lenaerts, Case W MacNamara, Valerie Mizrahi, Carl Nathan, David B Olsen, Tanya Parish, H Michael Petrassi, Alexander Pym, Kyu Y Rhee, Gregory T Robertson, Jeremy Michael Rock, Eric J Rubin, Betsy Russell, David G Russell, James C Sacchettini, Dirk Schnappinger, Michael Schrimpf, Anna M Upton, Peter Warner, Paul Graham Wyatt, Ying Yuan
The Tuberculosis Drug Accelerator at year 10: what have we learned? Nature medicine 27 (8) (2021)
Trever C Smith, Krista M Pullen, Michaela C Olson, Morgan E McNellis, Ian Richardson, Sophia Hu, Jonah Larkins-Ford, Xin Wang, Joel S Freundlich, D Michael Ando, Bree B Aldridge
Morphological profiling of tubercle bacilli identifies drug pathways of action. Proceedings of the National Academy of Sciences of the United States of America 117 (31) (2020)
Shuyi Ma, Suraj Jaipalli, Jonah Larkins-Ford, Jenny Lohmiller, Bree B Aldridge, David R Sherman, Sriram Chandrasekaran
Transcriptomic Signatures Predict Regulators of Drug Synergy and Clinical Regimen Efficacy against Tuberculosis. mBio 10 (6) (2019)
Murat Cokol, Nurdan Kuru, Ece Bicak, Jonah Larkins-Ford, Bree B Aldridge
Efficient measurement and factorization of high-order drug interactions in Mycobacterium tuberculosis. Science advances 3 (10) (2017)

Bree B Aldridge.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Bree B Aldridge